Literature DB >> 24467271

Hospital-based, acute care encounters after radiofrequency ablation of hepatic tumours.

Rebecca M Tuttle1, Justin P Fox, James R Ouellette, Minia Hellan.   

Abstract

BACKGROUND: The use of radiofrequency ablation (RFA) for cancer is increasing; however, post-discharge outcomes have not been well described. The aim of the present study was to determine rates of hospital-based, acute care utilization within 30 days of discharge after RFA.
METHODS: Using state-level data from California, patients were identified who were at least 40 years of age who underwent RFA of hepatic tumours without a concurrent liver resection from 2007-2011. Our primary outcome was hospital readmissions or emergency department visits within 30 days of discharge. A multivariable regression model was constructed to identify patient factors associated with these events.
RESULTS: The final sample included 1764 patients treated at 100 centres. Hospital readmissions (11.3/100 discharges), emergency department visits (6.0/100 discharges) and overall acute care utilization (17.3/100 discharges) were common. Most encounters occurred within 10 days of discharge for diagnoses related to the procedure. Patients with renal failure [adjusted odds ratio (AOR) = 1.98 (1.11-3.53)], obesity [AOR = 1.69 (1.03-2.77)], drug abuse [AOR = 2.95 (1.40-6.21)] or those experiencing a complication [AOR = 1.52 (1.07-2.15)] were more likely to have a hospital-based acute care encounter within 30 days of discharge.
CONCLUSIONS: Hospital-based acute care after RFA is common. Patients should be counselled regarding the potential for acute care utilization and interventions targeted to high-risk populations.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 24467271      PMCID: PMC4159458          DOI: 10.1111/hpb.12220

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  16 in total

1.  Adverse effects of radiofrequency ablation of liver tumours in the Netherlands.

Authors:  M C Jansen; F H van Duijnhoven; R van Hillegersberg; A Rijken; F van Coevorden; J van der Sijp; W Prevoo; T M van Gulik
Journal:  Br J Surg       Date:  2005-10       Impact factor: 6.939

2.  Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma.

Authors:  Nader N Massarweh; James O Park; Farhood Farjah; Raymond S W Yeung; Rebecca Gaston Symons; Thomas L Vaughan; Laura-Mae Baldwin; David R Flum
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

3.  Association of postdischarge complications with reoperation and mortality in general surgery.

Authors:  Hadiza S Kazaure; Sanziana A Roman; Julie A Sosa
Journal:  Arch Surg       Date:  2012-11

4.  Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.

Authors:  David Yu Greenblatt; Kaitlyn J Kelly; Victoria Rajamanickam; Yin Wan; Todd Hanson; Robert Rettammel; Emily R Winslow; Clifford S Cho; Sharon M Weber
Journal:  Ann Surg Oncol       Date:  2011-02-20       Impact factor: 5.344

5.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

6.  A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications.

Authors:  Elise H Lawson; Rachel Louie; David S Zingmond; Robert H Brook; Bruce L Hall; Lein Han; Michael Rapp; Clifford Y Ko
Journal:  Ann Surg       Date:  2012-12       Impact factor: 12.969

7.  Use of hospital-based acute care among patients recently discharged from the hospital.

Authors:  Anita A Vashi; Justin P Fox; Brendan G Carr; Gail D'Onofrio; Jesse M Pines; Joseph S Ross; Cary P Gross
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

8.  Hospital variation in readmission after coronary artery bypass surgery in California.

Authors:  Zhongmin Li; Ehrin J Armstrong; Ehrin J Amstrong; Joseph P Parker; Beate Danielsen; Patrick S Romano
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-09-04

9.  Short-term outcomes of ablation therapy for hepatic tumors: evidence from the 2006-2009 nationwide inpatient sample.

Authors:  Justin P Fox; Joshua Gustafson; Mayur M Desai; Minia Hellan; Thav Thambi-Pillai; James Ouellette
Journal:  Ann Surg Oncol       Date:  2012-05-17       Impact factor: 5.344

10.  Impact of infectious complications after elective surgery on hospital readmission and late deaths in the U.S. Medicare population.

Authors:  Todd R Vogel; Viktor Y Dombrovskiy; Stephen F Lowry
Journal:  Surg Infect (Larchmt)       Date:  2012-10-19       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.